Cargando…
Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer
Clinical optimism for dendritic cell vaccination against ovarian cancer has been tempered by the knowledge that tumors avail themselves of multiple mechanisms of immune evasion, thus blunting the efficacy of therapeutic vaccination. Mechanisms of immune suppression include infiltration by regulatory...
Autores principales: | Goyne, Hannah E., Cannon, Martin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831151/ https://www.ncbi.nlm.nih.gov/pubmed/24302925 http://dx.doi.org/10.3389/fimmu.2013.00382 |
Ejemplares similares
-
Dendritic Cell Vaccines in Ovarian Cancer
por: Zhang, Xi, et al.
Publicado: (2021) -
Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer
por: Zhang, Lei, et al.
Publicado: (2022) -
Lactate-Dependent Regulation of Immune Responses by Dendritic Cells and Macrophages
por: Manoharan, Indumathi, et al.
Publicado: (2021) -
Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
por: Jiang, Li, et al.
Publicado: (2018) -
Dendritic Cell-Targeted Vaccines
por: Cohn, Lillian, et al.
Publicado: (2014)